Global Pharmaceuticals & Biotech Breakout Stocks

Insmed

Market Cap: US$29.4b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Charles River Laboratories International

Market Cap: US$13.2b

Charles River Laboratories International, Inc.

Halozyme Therapeutics

Market Cap: US$11.6b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.

Twist Bioscience

Market Cap: US$7.8b

Manufactures and sells synthetic DNA-based products.

10x Genomics

Market Cap: US$7.6b

Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.

Genscript Biotech

Market Cap: HK$53.7b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Harbin Pharmaceutical Group

Market Cap: CN¥20.8b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

Iovance Biotherapeutics

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

AbCellera Biologics

Market Cap: US$2.9b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

GemPharmatech

Market Cap: CN¥16.2b

A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.

HitGen

Market Cap: CN¥15.1b

Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.

Sino BiologicalInc

Market Cap: CN¥14.5b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

AcrobiosystemsLtd

Market Cap: CN¥13.8b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.

Shanghai Medicilon

Market Cap: CN¥13.6b

A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.

Septerna

Market Cap: US$1.8b

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

PharmaBlock Sciences (Nanjing)

Market Cap: CN¥11.6b

Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥7.8b

Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.

PharmaResources (Shanghai)

Market Cap: CN¥6.8b

Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.

Anhui Wanbang Pharmaceutical TechnologyLtd

Market Cap: CN¥6.5b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

Bide Pharmatech

Market Cap: CN¥6.5b

Engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China.

Geron

Market Cap: US$950.9m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

GlaxoSmithKlineE

Market Cap: ج.م45.9b

Engages in production of pharmaceutical chemicals.

R&G PharmaStudies

Market Cap: CN¥6.0b

Operates as a clinical trial outsourcing service provider in China and internationally.

Aarti Pharmalabs

Market Cap: ₹80.1b

Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥4.9b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Immix Biopharma

Market Cap: US$724.7m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Silence Therapeutics

Market Cap: US$693.1m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Boji Medical TechnologyLtd

Market Cap: CN¥4.5b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Novoprotein Scientific

Market Cap: CN¥3.9b

Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

Evolus

Market Cap: US$500.0m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

OmniAb

Market Cap: US$492.9m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Shanghai Kai Kai Industry

Market Cap: CN¥3.1b

Engages in the wholesale and retail of pharmaceutical products in China.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م23.0b

Develops, produces, and sells pharmaceutical products in Egypt.

Hansa Biopharma

Market Cap: SEK 4.1b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

Fennec Pharmaceuticals

Market Cap: US$380.0m

Operates as a commercial stage biopharmaceutical company in the United States.

Foghorn Therapeutics

Market Cap: US$370.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.